<DOC>
	<DOCNO>NCT01813565</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety additional hyaluronic acid/chondroitin sulfate transurethral resection bladder ulcer patient interstitial cystitis .</brief_summary>
	<brief_title>The Efficacy Additional Intravesical Instillation Hyaluronic Acid/Chondroitin Sulfate Transurethral Resection Bladder Ulcer Patients With Interstitial Cystitis/Bladder Pain Syndrome .</brief_title>
	<detailed_description>This randomize , parallel , 6 month period study .</detailed_description>
	<mesh_term>Cystitis</mesh_term>
	<mesh_term>Cystitis , Interstitial</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>1. must experience bladder pain , urinary urgency urinary frequency , least 6 month prior entry study 2 . Pain VAS ≥4 3 . O'LearySant Interstitial Cystitis questionnaire ( ICQ ) symptom problem ≥ 12 ( pain ≥2 , nocturia ≥ 2 ) 4 . PUF score ≥ 13 5. cystoscopic record within 2 year 6 . Hunner ulcer lesion cystoscopic find 1 . Scheduled use intravesical therapy ( eg , bladder distention , transurethral resection bladder ulcer , instillation ) within 6months prior study use pentosan polysulfate sodium within 1 month prior study 2 . Patients pregnancy , childbearing age without contraception 3 . Patients void volume &lt; 40 , &gt; 400ml 4 . Patients microscopic hematuria , ( ≥1+ dipstick ) , If exclude evidence neoplastic tumor examination 5 . Patients urine culture show evidence urinary tract infection 1month prior study 6 . Accompanied medical problem Tuberculosis urinary system Bladder cancer , urethral cancer , prostate cancer Recurrent cystitis anatomical disorder 7 . Patients prior surgery ( eq , bladder augmentation , cystectomy 8 . Patients neurologic disorder 9 . Patients indwell catheter intermittent selfcatheterization 10 . Patients psychologic problem</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>